Nitto Avecia

Nitto Avecia is a leading contract development and manufacturing organization (CDMO) specializing in oligonucleotide therapeutics. They provide comprehensive services from early-stage development to commercial manufacturing, catering to pharmaceutical and biotech companies. The company generates revenue through its specialized expertise in oligonucleotide synthesis, process development, and analytical services. Founded in 1995 and acquired by Nitto Denko Corporation in 2011, Nitto Avecia has a rich history of innovation and growth in the biopharmaceutical sector.

Recent Posts by Nitto Avecia

1-20 of 74